Harry Skip Kiil
CIK 1708062 · EVP & President Cardiovascular · last filed 2026-09-17
Harry Skip Kiil is an EVP & President Cardiovascular who has filed 14 SEC Form 4 insider transactions across 1 company since 2025. The most recent filing shows the insider sold $138.9K of MDT on Sep 17, 2026. Across all open-market trades the lifetime net is −$6.4M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $4.2M across reported positions. 15 SEC filings were submitted jointly with Medtronic plc. 4 Form 144 notices of planned sales are also on file; the latest, for MDT on Sep 16, 2026, lists the filer as an officer.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
MDT price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
SAN DIEGO, CA 92121
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| MDT | EVP & President Cardiovascular | 42,186 | $100.28 | $4.23M | -$6.40M | 10 | 2026-09-17 |
Recent Filings
14 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-09-17 | MDT | Sell (S) | −1,483 | -$138.9K | EDGAR |
| 2026-09-16 | MDT | Notice (144) Officer · Planned Sep 16, 2026 Sold: Form 4 filed Sep 17, 2026 |
−1,483 | -$138.9K | EDGAR |
| 2026-08-04 | MDT | Mixed | +6,156 | -$262.5K | EDGAR |
| 2026-06-09 | MDT | Sell (S) | −4,189 | -$337.0K | EDGAR |
| 2026-06-08 | MDT | Notice (144) Officer · Planned Jun 8, 2026 Sold: Form 4 filed Jun 9, 2026 |
−4,189 | -$337.0K | EDGAR |
| 2026-06-08 | MDT | Tax (F) | −6,817 | -$568.0K | EDGAR |
| 2026-05-28 | MDT | Exer (M) | +15,195 | $0 | EDGAR |
| 2026-02-26 | MDT | Mixed | −1,648 | -$507.7K | EDGAR |
| 2026-02-19 | MDT | Notice (144) Officer · Planned Feb 19, 2026 Sold: Form 4 filed Feb 26, 2026 |
−52,524 | -$5.13M | EDGAR |
| 2025-12-09 | MDT | Tax (F) | −1,702 | -$172.5K | EDGAR |
10b5-1: the filer ticked the box for trades made under a Rule 10b5-1 trading plan, which sets the sales (or buys) in advance, so they say less about the insider's view at the time than a discretionary trade. The plan's adoption date is shown when the filing's footnotes give it.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment, and an amended or cancelled notice is not listed. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes. Someone who is no longer an officer or director (or never was) files no Form 4, so for them a sale shows up only on a later notice, which lists the seller's sales from the 3 months before it. "No sale on file" means neither record shows one; a dash in Net $ means the value filed on the notice doesn't fit the stock's price (likely a typo).